News Releases

  • Cockrell School Honors Three Outstanding Young Engineering Graduates

    The Cockrell School's three Outstanding Young Engineering Graduates for 2016 are entrepreneurs, finance experts, CEOs and thought leaders in their fields. We honor them for their outstanding professional achievements, dedication to public service and support of higher education. Including this year's recipients, 31 alumni have been recognized with this award.

  • Flu Vaccine’s Effectiveness Can Be Improved, New Findings Suggest

    A team of engineers and scientists at The University of Texas at Austin is reporting new findings on how the influenza vaccine produces antibodies that protect against disease, research that suggests that the conventional flu vaccine can be improved. The findings were reported in the journal Nature Medicine on Nov. 7.

  • UT System Board of Regents Commits Funding for New Energy Engineering Building

    Today, the UT System Board of Regents committed $100 million in Permanent University Fund (PUF) bond proceeds to support the construction of an energy engineering building in the Cockrell School of Engineering at The University of Texas at Austin. The building is the next in the Cockrell School’s master facility plan and will be focused on energy-related education and research. Before construction can begin, two additional levels of approval from the Regents will be required, and the school will also need to secure $50 million in philanthropic support.

  • Statoil Partnership Bolsters UT Austin Graduate Research

    Statoil, an international energy company based in Norway, has signed a $2.5 million partnership renewal agreement to support graduate student research focused on geology, geophysics and petroleum engineering at The University of Texas at Austin.

  • New Clinical Partnership Uses Advanced Imaging Methods to Fight Breast Cancer

    In partnership with Seton Healthcare Family, Texas Oncology and Austin Radiological Association, The University of Texas at Austin has embarked on a two-year clinical study to test advanced imaging methods that could provide patients and physicians with new, valuable information on how to treat breast cancer in patients.